Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

26. April 2018 07:00 ET | Quelle: Stemline Therapeutics, Inc.

Stemline Therapeutics Announces Clinical Presentations of SL-801 and SL-701 at the Upcoming ASCO Annual Meeting

NEW YORK, April 26, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today that...
16. April 2018 07:00 ET | Quelle: Stemline Therapeutics, Inc.

Stemline Therapeutics Expands Board of Directors; Further Enhances Commercial Expertise with Appointment of Darren Cline

NEW YORK, April 16, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, today announced expansion...
05. April 2018 07:00 ET | Quelle: Stemline Therapeutics, Inc.

Stemline Therapeutics Announces Start of Rolling BLA Submission for SL-401

NEW YORK, April 05, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today that it has...
19. März 2018 07:30 ET | Quelle: Stemline Therapeutics, Inc.

Stemline Therapeutics to Present at the Oppenheimer 28th Annual Healthcare Conference

NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today that Ivan...
16. März 2018 07:30 ET | Quelle: Stemline Therapeutics, Inc.

Stemline Therapeutics Reports Fourth Quarter 2017 Financial Results

NEW YORK, March 16, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced...
08. März 2018 07:30 ET | Quelle: Stemline Therapeutics, Inc.

Stemline Therapeutics to Present at Upcoming Investor Conferences

NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers,...
26. Januar 2018 10:21 ET | Quelle: Stemline Therapeutics, Inc.

Stemline Therapeutics Closes $59.6 Million Public Offering of Common Stock

NEW YORK, Jan. 26, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, today announced the closing...
24. Januar 2018 07:00 ET | Quelle: Stemline Therapeutics, Inc.

Stemline Therapeutics Prices $51.8 Million Public Offering of Common Stock

NEW YORK, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, today announced the pricing...
22. Januar 2018 16:01 ET | Quelle: Stemline Therapeutics, Inc.

Stemline Therapeutics Announces Proposed Public Offering of Common Stock

NEW YORK, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, today announced that it...
04. Januar 2018 08:00 ET | Quelle: Stemline Therapeutics, Inc.

Stemline Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference

NEW YORK, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers...

Vorherige Seite

Nächste Seite